D. Harats et al., TARGETING GENE-EXPRESSION TO THE VASCULAR WALL IN TRANSGENIC MICE USING THE MURINE PREPROENDOTHELIN-1 PROMOTER, The Journal of clinical investigation, 95(3), 1995, pp. 1335-1344
To develop a system for overexpressing genes in the vascular wall, we
created transgenic mice using the reporter gene luciferase and the mur
ine preproendothelin-1 promoter. In vitro analysis suggested that the
murine 5'-flanking region contained endothelial-specific elements in a
5.9-kb fragment. Five transgenic mice colonies established from indep
endent founders all exhibited the highest level of luciferase activity
in the aorta with up to 8,540 light units per microgram of protein. I
mmunohistochemistry with anti-luciferase antisera revealed high levels
of expression in the endothelial cells of both large and small arteri
es and lower levels of expression in veins and capillaries. Significan
t expression was also seen in arterial smooth muscle cells and in sele
ct epithelial surfaces which is consistent with the known distribution
of endothelin-1 in mammals. To further demonstrate the targeting capa
bility of this system, we overexpressed the lipid-peroxidating enzyme,
human 15-lipoxygenase, in the vessel wall of transgenic mice. As with
luciferase, expression of active enzyme and immunohistochemical local
ization in vascular cells were documented in transgenic animals. Hence
, this new system can be used to direct expression of molecules to the
vascular wall for the purpose of examining the biological significanc
e of either overexpression or inhibition of select proteins.